GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **901 - 925** of **4050** in total

« First

‹ Prev

…

33

34

35

36

37

38

39

40

41

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgA	Patient 1	10	moderate	G76615YG	337
IgA	Patient 1	22	moderate	G76615YG	324
IgA	Patient 1	6	moderate	G76615YG	339
IgG	Patient 1	10	moderate	G76615YG	23
IgG	Patient 1	22	moderate	G76615YG	34
IgM	Patient 1	10	moderate	G76615YG	32
IgM	Patient 1	22	moderate	G76615YG	166
IgA	Patient 2	15	mild	G76615YG	252
IgA	Patient 2	24	mild	G76615YG	294
IgG	Patient 2	15	mild	G76615YG	30
IgG	Patient 2	24	mild	G76615YG	29
IgM	Patient 2	15	mild	G76615YG	57
IgM	Patient 2	24	mild	G76615YG	45
IgG	Patient 1	6	moderate	G76615YG	23
IgM	Patient 1	6	moderate	G76615YG	30
IgA	Patient 2	3	mild	G76615YG	252
IgG	Patient 2	3	mild	G76615YG	27
IgM	Patient 2	3	mild	G76615YG	40
IgA	Patient 3	-180	mild	G76615YG	2131
IgA	Patient 3	11	mild	G76615YG	2157
IgG	Patient 3	-180	mild	G76615YG	1210
IgM	Patient 3	-180	mild	G76615YG	6196
IgA	Patient 3	4	mild	G76615YG	2367
IgG	Patient 3	11	mild	G76615YG	1785
IgG	Patient 3	4	mild	G76615YG	1694